Thank you for your interest in this workshop. Please fill in the form and submit to access the recording and discover how OGM benefits clinical research in cancer.

Bionano Corporate Workshop #1: Maximizing Detection of Pathogenic Structural Variants Across Hematological Malignancies with Optical Genome Mapping.

Speakers:

• Alka Chaubey, PhD, FACMB | Chief Medical Officer, Bionano
• Adam Smith, PhD, FCCMG, FACMG | Director, Cancer Cytogenetic Laboratory and Clinician Investigator, University Health Network, Toronto
• Nikhil Sahajpal, PhD | ABMGG Fellow, Greenwood Genetic Center
• Rashmi Kanagal-Shamanna, MD | Director, Molecular Diagnostic Lab, MD Anderson Cancer Center